Inhibitors of infamous Ras oncogene reported by Genentech researchers at ASCB annual meeting
Monday, December 5, 2011 - 13:01
in Health & Medicine
A drug discovery team at Genentech, Inc., has uncovered a chink in the molecular armor of Ras, the most commonly occurring oncogene, which is a gene that when mutated has the potential of causing...